O uso de Zolpidem para tratamento de insônia

Detalhes bibliográficos
Autor(a) principal: Fernanda Oliveira Goulart , Yara
Data de Publicação: 2024
Outros Autores: Pizzo Pereira, Júlia, de Oliveira Silva , Ingrid, Gastaldelo , Victoria, Cruz Magalhães , Thainá, Pedroso Ribeiro , Ingrid, Cristine Marini, Danyelle
Tipo de documento: Artigo
Idioma: por
Título da fonte: Brazilian Journal of Implantology and Health Sciences
Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/1289
Resumo: More than 73 million Brazilians suffer from insomnia, mainly in the country's large centers. Among the main causes of this problem are stress, anxiety, irregular sleeping habits, lifestyle and use of screens (cell phone, TV, etc.) at night. To treat this problem, many doctors prescribe zolpidem to their patients, as the medication is used to treat this sleep disorder. This research aimed to evaluate the use of zolpidem as a non-benzoadizepine sedative-hypnotic prescribed for insomnia. To this end, an exploratory research was carried out, a questionnaire for data collection with 12 questions was formulated and applied to 100 people, by form, who already use zolpidem. Of these participants, the majority were women (72%), the majority were between 25 and 35 years old (36%) and the majority had been using the medication for more than 1 year (58%). The majority reported an improvement in sleep quality after using the medication (97%) and the majority did not need to increase the medication dose (75%). Furthermore, the majority rarely forgot to administer the medication (76%), the majority never stopped administering it due to symptom improvement (71%) or worsening (92%) and the majority never administered the medication on their own (71% ). The majority administer another medication along with zolpidem (80%), the majority did not have any adverse reactions (74%), the majority did not attempt to wean off the medication (80%) and the majority never provided pills to people close to them (91% ). It is concluded that zolpidem is safe to treat sleep disorders with medical advice, and prolonged use should be avoided to avoid possible adverse reactions and dependence. The need for individualized assessment of each patient is evident. Keywords: 1. Zolpidem. 2. Insomnia. 3. Adverse reactions. 4. Medicine. 5. Sleep.
id GOE-1_71d104a9e9c8979f405532828f0b34e7
oai_identifier_str oai:ojs.bjihs.emnuvens.com.br:article/1289
network_acronym_str GOE-1
network_name_str Brazilian Journal of Implantology and Health Sciences
repository_id_str
spelling O uso de Zolpidem para tratamento de insônia ZolpidemInsôniaReações AdversasMedicamentoSonoMore than 73 million Brazilians suffer from insomnia, mainly in the country's large centers. Among the main causes of this problem are stress, anxiety, irregular sleeping habits, lifestyle and use of screens (cell phone, TV, etc.) at night. To treat this problem, many doctors prescribe zolpidem to their patients, as the medication is used to treat this sleep disorder. This research aimed to evaluate the use of zolpidem as a non-benzoadizepine sedative-hypnotic prescribed for insomnia. To this end, an exploratory research was carried out, a questionnaire for data collection with 12 questions was formulated and applied to 100 people, by form, who already use zolpidem. Of these participants, the majority were women (72%), the majority were between 25 and 35 years old (36%) and the majority had been using the medication for more than 1 year (58%). The majority reported an improvement in sleep quality after using the medication (97%) and the majority did not need to increase the medication dose (75%). Furthermore, the majority rarely forgot to administer the medication (76%), the majority never stopped administering it due to symptom improvement (71%) or worsening (92%) and the majority never administered the medication on their own (71% ). The majority administer another medication along with zolpidem (80%), the majority did not have any adverse reactions (74%), the majority did not attempt to wean off the medication (80%) and the majority never provided pills to people close to them (91% ). It is concluded that zolpidem is safe to treat sleep disorders with medical advice, and prolonged use should be avoided to avoid possible adverse reactions and dependence. The need for individualized assessment of each patient is evident. Keywords: 1. Zolpidem. 2. Insomnia. 3. Adverse reactions. 4. Medicine. 5. Sleep.Mais de 73 milhões de brasileiros sofrem com insônia, principalmente nos grandes centros do país. Entre as principais causas para esse problema estão o estresse, ansiedade, hábitos de sono irregulares, estilo de vida e uso de telas (celular, TV etc.) no período noturno. Para o tratamento desse problema, muitos médicos prescrevem o zolpidem para seus pacientes, visto que o medicamento serve para o tratamento desse distúrbio do sono. Essa pesquisa visou avaliar o uso do medicamento zolpidem como um sedativo-hipnótico não benzoadizepínico prescrito para insônia. Para isso foi feito uma pesquisa exploratória, formulado um questionário para levantamento de dados com 12 perguntas e aplicado a 100 pessoas, via formulário, que já fazem uso do zolpidem. Destes participantes, a maioria foram mulheres (72%), a maioria tem entre 25 e 35 anos (36%) e a maioria faz uso do medicamento a mais de 1 ano (58%). A maioria relatou melhoria na qualidade do sono após o uso do medicamento (97%) e a maioria não teve necessidade de aumento da dose do medicamento (75%). Além disso, a maioria raramente esqueceu de administrar o medicamento (76%), a maioria nunca deixou de administrar por melhora dos sintomas (71%) ou por piora (92%) e a maioria nunca administrou o medicamento por conta própria (71%). A maioria administra outro medicamento junto com o zolpidem (80%), a maioria não teve nenhuma reação adversa (74%), a maioria não tentou o desmame do medicamento (80%) e a maioria nunca forneceu comprimidos para pessoas próximas (91%). Conclui-se que o zolpidem é seguro para tratar distúrbios do sono com orientações médicas, devendo ser evitado o uso prolongado para evitar possíveis reações adversas e dependência. Fica evidente a necessidade de avaliação individualizada de cada paciente. Palavras-chave: 1. Zolpidem. 2. Insônia. 3. Reações adversas. 4. Medicamento. 5. Sono.Specialized Dentistry Group2024-01-25info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/128910.36557/2674-8169.2024v6n1p1806-1823Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 1 (2024): BJIHS QUALIS B3; 1806-1823Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 1 (2024): BJIHS QUALIS B3; 1806-1823Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 1 (2024): BJIHS QUALIS B3; 1806-18232674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1289/1507Copyright (c) 2024 Yara Fernanda Oliveira Goulart , Júlia Pizzo Pereira, Ingrid de Oliveira Silva , Victoria Gastaldelo , Thainá Cruz Magalhães , Ingrid Pedroso Ribeiro , Danyelle Cristine Marinihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFernanda Oliveira Goulart , YaraPizzo Pereira, Júliade Oliveira Silva , IngridGastaldelo , VictoriaCruz Magalhães , ThaináPedroso Ribeiro , IngridCristine Marini, Danyelle2024-01-25T19:55:19Zoai:ojs.bjihs.emnuvens.com.br:article/1289Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-01-25T19:55:19Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false
dc.title.none.fl_str_mv O uso de Zolpidem para tratamento de insônia
title O uso de Zolpidem para tratamento de insônia
spellingShingle O uso de Zolpidem para tratamento de insônia
Fernanda Oliveira Goulart , Yara
Zolpidem
Insônia
Reações Adversas
Medicamento
Sono
title_short O uso de Zolpidem para tratamento de insônia
title_full O uso de Zolpidem para tratamento de insônia
title_fullStr O uso de Zolpidem para tratamento de insônia
title_full_unstemmed O uso de Zolpidem para tratamento de insônia
title_sort O uso de Zolpidem para tratamento de insônia
author Fernanda Oliveira Goulart , Yara
author_facet Fernanda Oliveira Goulart , Yara
Pizzo Pereira, Júlia
de Oliveira Silva , Ingrid
Gastaldelo , Victoria
Cruz Magalhães , Thainá
Pedroso Ribeiro , Ingrid
Cristine Marini, Danyelle
author_role author
author2 Pizzo Pereira, Júlia
de Oliveira Silva , Ingrid
Gastaldelo , Victoria
Cruz Magalhães , Thainá
Pedroso Ribeiro , Ingrid
Cristine Marini, Danyelle
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Fernanda Oliveira Goulart , Yara
Pizzo Pereira, Júlia
de Oliveira Silva , Ingrid
Gastaldelo , Victoria
Cruz Magalhães , Thainá
Pedroso Ribeiro , Ingrid
Cristine Marini, Danyelle
dc.subject.por.fl_str_mv Zolpidem
Insônia
Reações Adversas
Medicamento
Sono
topic Zolpidem
Insônia
Reações Adversas
Medicamento
Sono
description More than 73 million Brazilians suffer from insomnia, mainly in the country's large centers. Among the main causes of this problem are stress, anxiety, irregular sleeping habits, lifestyle and use of screens (cell phone, TV, etc.) at night. To treat this problem, many doctors prescribe zolpidem to their patients, as the medication is used to treat this sleep disorder. This research aimed to evaluate the use of zolpidem as a non-benzoadizepine sedative-hypnotic prescribed for insomnia. To this end, an exploratory research was carried out, a questionnaire for data collection with 12 questions was formulated and applied to 100 people, by form, who already use zolpidem. Of these participants, the majority were women (72%), the majority were between 25 and 35 years old (36%) and the majority had been using the medication for more than 1 year (58%). The majority reported an improvement in sleep quality after using the medication (97%) and the majority did not need to increase the medication dose (75%). Furthermore, the majority rarely forgot to administer the medication (76%), the majority never stopped administering it due to symptom improvement (71%) or worsening (92%) and the majority never administered the medication on their own (71% ). The majority administer another medication along with zolpidem (80%), the majority did not have any adverse reactions (74%), the majority did not attempt to wean off the medication (80%) and the majority never provided pills to people close to them (91% ). It is concluded that zolpidem is safe to treat sleep disorders with medical advice, and prolonged use should be avoided to avoid possible adverse reactions and dependence. The need for individualized assessment of each patient is evident. Keywords: 1. Zolpidem. 2. Insomnia. 3. Adverse reactions. 4. Medicine. 5. Sleep.
publishDate 2024
dc.date.none.fl_str_mv 2024-01-25
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://bjihs.emnuvens.com.br/bjihs/article/view/1289
10.36557/2674-8169.2024v6n1p1806-1823
url https://bjihs.emnuvens.com.br/bjihs/article/view/1289
identifier_str_mv 10.36557/2674-8169.2024v6n1p1806-1823
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://bjihs.emnuvens.com.br/bjihs/article/view/1289/1507
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Specialized Dentistry Group
publisher.none.fl_str_mv Specialized Dentistry Group
dc.source.none.fl_str_mv Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 1 (2024): BJIHS QUALIS B3; 1806-1823
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 1 (2024): BJIHS QUALIS B3; 1806-1823
Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 1 (2024): BJIHS QUALIS B3; 1806-1823
2674-8169
reponame:Brazilian Journal of Implantology and Health Sciences
instname:Grupo de Odontologia Especializada (GOE)
instacron:GOE
instname_str Grupo de Odontologia Especializada (GOE)
instacron_str GOE
institution GOE
reponame_str Brazilian Journal of Implantology and Health Sciences
collection Brazilian Journal of Implantology and Health Sciences
repository.name.fl_str_mv Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)
repository.mail.fl_str_mv journal.bjihs@periodicosbrasil.com.br
_version_ 1796798443670208512